CanReg Inc. selects QUMAS R&D Solution for complete Content and Submission Management

Global Regulatory Consultancy Will Use QUMAS to Help Clients Expedite Regulatory Submissions

Florham Park, NJ — August 28, 2007 - QUMAS, a leading provider of quality management and regulatory affairs solutions, today announced that CanReg Inc., one of the world's largest global regulatory consulting firms, has selected the QUMAS R&D Solution™ for content and submissions management. CanReg has more than 400 active life science clients around the world. By purchasing the QUMAS R&D Solution, CanReg will receive a bundled solution for complete content and submission management. This will significantly expedite CanReg's high volume of submissions while maintaining or enhancing overall project quality.

CanReg has more than 100 employees who focus on the regulatory needs of pharmaceutical, biotechnology and medical device companies in the United States, Canada and Europe. "Leadership in our profession is directly related to the quality of the people, processes and systems that we can provide to our clients," said Ted Hanebach, Director of Regulatory Standards at CanReg. "Our partnership with QUMAS allows us to streamline submission processes, reduce costs, and maintain an optimal client experience."

CanReg will use the QUMAS R&D Solution to help its clients by integrating document and submissions management into one seamless lifecycle. The QUMAS R&D Solution assists life sciences companies in expediting the new drug application process with better quality submissions, fewer iterations and shortened review and approval cycles. It provides CanReg with an effective all-in-one R&D strategy, as well as significantly reduced costs of ownership both at deployment and over time.

"We're seeing a lot of traction with the QUMAS R&D Solution because it integrates all of the key aspects of submissions into one easy-to-use bundle," said Ken Hayward, executive vice president of QUMAS. "The R&D Solution and the recently announced QUMAS P&P Solution for financial services are the first of several bundled solutions in the life sciences and financial services markets. We anticipate continued demand for these solutions since they offer customers complete solutions to solve their compliance issues."

About CanReg Inc

CanReg is a company dedicated exclusively to regulatory affairs consulting. More than 100 in-house consultants and staff support our pharmaceutical, biotechnology and medical device clients around the world. Senior consultants at CanReg have more than 30 years experience dealing with FDA, Health Canada, and European regulatory agencies. For many clients this translates into shortened time-to-clinic and ultimately, time-to-market.


QUMAS is a leading developer of enterprise compliance management solutions designed to help life sciences organizations meet industry and government standards for 21 CFR Part 11, cGxP, Quality, Regulatory Affairs and Clinical Operations. With over a decade of experience, QUMAS is helping companies accelerate business processes, reduce costs and improve quality. From content lifecycle management, business process and change management to reporting and analysis, QUMAS Compliance Suite is successfully enabling global life science organizations to proactively manage their regulated content and processes in a secure and compliant way.

For more information visit

# # #

All trade names, trademarks, and service marks are the rightful property of their respective owners